ArticleInfection and drug resistance2019

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study.

Xiaoning Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.